Moneycontrol PRO
Live: Live: Which RJ stock is worth betting on

Lupin acquires Melbourne-based drug maker SCP to bolster Australia generics business

As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million

July 30, 2021 / 12:19 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Lupin's Australian subsidiary Generic Health on July 30 said it has entered into a definitive agreement to acquire 100 percent of the shares of privately-held Southern Cross Pharma Pty (SCP).

Lupin did not disclose the financials of the deal.

The Melbourne-based SCP is engaged in developing, registering, and distributing generic products.

As a part of the transaction, Lupin will gain access to over 60 registered products having sales of over AUD 30 million (approximately $22 million).

"This will significantly increase Lupin’s value proposition and market share in the Australian market," Lupin said.

Close

“This is an important acquisition for our Australian entity and is aligned with Lupin’s strategy to expand and deepen our presence in select markets of focus," Nilesh Gupta, Managing Director of Lupin said.

"The Southern Cross Pharma portfolio builds on our existing portfolio of prescription generics, over the counter and specialty range of products. This investment significantly increases our scale in Australia and reinforces our commitment to patients in Australia,” Gupta added.

SCP supplies prescription products for retail pharmacies and direct marketing of its own-brand product, SXP, to the hospital sector. Southern Cross Pharma now has over 330 entries on the Australian Register of Therapeutic Goods.

Generic Health Pty (GH), is a 100 percent subsidiary of Lupin. GH is the fourth largest and one of the fastest-growing generic pharmaceutical companies in Australia. GH markets and distributes over 180 generic products and OTC products under its Generic Health and Pharmacy Action brands through retail and hospital pharmacies across Australia.
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Jul 30, 2021 12:19 pm
Sections
ISO 27001 - BSI Assurance Mark